Verastem, Inc.
Clinical trials sponsored by Verastem, Inc., explained in plain language.
-
New hope for rare ovarian cancer: drug combo enters final testing phase
Disease control Recruiting nowThis phase 3 study tests whether a combination of two drugs (avutometinib and defactinib) works better than standard treatments for people with recurrent low-grade serous ovarian cancer. About 270 participants whose cancer has returned after platinum-based therapy will be randoml…
Phase: PHASE3 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated May 26, 2026 08:20 UTC
-
New pill targets hard-to-treat KRAS G12D cancers in early trial
Disease control Recruiting nowThis study tests a new oral drug, VS-7375, in people with advanced solid tumors (like pancreatic, lung, or colorectal cancer) that have a specific KRAS G12D mutation. The trial will first find the safest dose, then check if the drug shrinks tumors when used alone or with other ca…
Phase: PHASE1, PHASE2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated May 18, 2026 11:59 UTC